| pubmed-article:16951244 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0029456 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0853879 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0244404 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0596244 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0232970 | lld:lifeskim |
| pubmed-article:16951244 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:16951244 | pubmed:issue | 17 | lld:pubmed |
| pubmed-article:16951244 | pubmed:dateCreated | 2006-9-4 | lld:pubmed |
| pubmed-article:16951244 | pubmed:abstractText | To assess the effect of raloxifene, indicated for osteoporosis treatment and prevention, on invasive breast cancer in subgroups of postmenopausal women defined by risk factors for breast cancer. | lld:pubmed |
| pubmed-article:16951244 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16951244 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16951244 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16951244 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16951244 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16951244 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16951244 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16951244 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16951244 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16951244 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:CauleyJane... | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:CummingsSteve... | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:LippmanMarc... | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:MartinoSilvan... | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:MershonJohn... | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:DowsettSherie... | lld:pubmed |
| pubmed-article:16951244 | pubmed:author | pubmed-author:DischDamon... | lld:pubmed |
| pubmed-article:16951244 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16951244 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:16951244 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:16951244 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16951244 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16951244 | pubmed:pagination | 5242-7 | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:meshHeading | pubmed-meshheading:16951244... | lld:pubmed |
| pubmed-article:16951244 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16951244 | pubmed:articleTitle | Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk. | lld:pubmed |
| pubmed-article:16951244 | pubmed:affiliation | Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA. lippmanm@umich.edu | lld:pubmed |
| pubmed-article:16951244 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16951244 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16951244 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16951244 | lld:pubmed |
